Endo International | DEBITO



DEBITO Cambiamento Data
AbbVie USD 1000K 70.48B 2025-09
Amarin USD 0 0 2025-03
ANI Pharmaceuticals USD 620.31M 1.25M 2025-09
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Coherus Biosciences USD 294.92M 1.25M 2025-03
Eli Lilly USD 42.51B 2.6B 2025-09
Heron Therapeutics USD 149.65M 157K 2024-09
Hikma Pharmaceutical USD 1.56B 252M 2025-06
Ligand Pharmaceuticals USD 5.74M 5.72M 2025-06
Merck USD 41.37B 5.97B 2025-09
Novartis USD 32.64B 1.37B 2025-06
Pacira USD 376.72M 203.77M 2025-09
Perrigo USD 3.65B 454.7M 2025-06
Pfizer USD 60.85B 78M 2025-09
Phibro Animal Health USD 474.17M 730K 2024-09
Supernus Pharmaceuticals USD 31.77M 531K 2025-06
Takeda JPY 4.85T 208B 2025-12
Teva Pharmaceutical Industries USD 17.07B 450M 2025-09
Xeris Pharmaceuticals USD 257.65M 431K 2025-09
Zoetis USD 7.27B 482M 2025-09


Endo International DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.